Abiopharma

🔍 Kumar Neil (Director)

Company: BridgeBio Pharma, Inc. (BBIO)

Report Date: 2026-01-08

Detailed Transactions and Holdings:

• Sold 11,515 shares of Common Stock at $73.6446 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 744,171.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 8,085 shares of Common Stock at $74.3773 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 736,086.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 400 shares of Common Stock at $75.1602 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 735,686.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 11,565 shares of Common Stock at $73.6542 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,546,882.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
• Sold 8,135 shares of Common Stock at $74.3775 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,538,747.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
• Sold 300 shares of Common Stock at $75.2033 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,538,447.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 2,151 shares of Common Stock at $75.752 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 733,535.00 | transaction_form_type: 4 | Footnotes: F1, F8, F3
• Sold 6,955 shares of Common Stock at $76.7173 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 726,580.00 | transaction_form_type: 4 | Footnotes: F1, F9, F3
• Sold 10,519 shares of Common Stock at $77.6086 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 716,061.00 | transaction_form_type: 4 | Footnotes: F1, F10, F3
• Sold 375 shares of Common Stock at $78.192 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 715,686.00 | transaction_form_type: 4 | Footnotes: F1, F11, F3
• Sold 1,401 shares of Common Stock at $75.6088 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,537,046.00 | transaction_form_type: 4 | Footnotes: F1, F12, F3
• Sold 6,067 shares of Common Stock at $76.527 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,530,979.00 | transaction_form_type: 4 | Footnotes: F1, F13, F3
• Sold 10,677 shares of Common Stock at $77.4577 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,520,302.00 | transaction_form_type: 4 | Footnotes: F1, F14, F3
• Sold 1,855 shares of Common Stock at $78.1035 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,518,447.00 | transaction_form_type: 4 | Footnotes: F1, F15, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | shares_owned_after: 228,776.00

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
• F2: Represents the weighted average sale price of the shares sold from $73.05 to $74.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F3: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
• F4: Represents the weighted average sale price of the shares sold from $74.06 to $74.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F5: Represents the weighted average sale price of the shares sold from $75.09 to $75.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F6: Represents the weighted average sale price of the shares sold from $73.08 to $74.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F7: Represents the weighted average sale price of the shares sold from $74.08 to $75.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F8: Represents the weighted average sale price of the shares sold from $75.12 to $76.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F9: Represents the weighted average sale price of the shares sold from $76.13 to $77.125 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F10: Represents the weighted average sale price of the shares sold from $77.16 to $78.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F11: Represents the weighted average sale price of the shares sold from $78.16 to $78.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F12: Represents the weighted average sale price of the shares sold from $74.99 to $75.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F13: Represents the weighted average sale price of the shares sold from $75.99 to $76.985 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F14: Represents the weighted average sale price of the shares sold from $76.99 to $77.96 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
• F15: Represents the weighted average sale price of the shares sold from $78.00 to $78.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.